Milestones
- CE Mark approval25 Aug 2023Complete.
- FDA approval26 Apr 2024Complete.
- 12-month clinical data published23 Jan 2025Complete.
by MedtronicIE
Provide personalized chronic pain relief that adapts to patient movement.
FDA approved Apr 2024; senses 50x/s, 3T MRI access, 12-month clinical data Jan 2025.
Updated 23 Jan 2025Checked 11 Oct0 updates this week
Electrodes detect evoked compound action potentials (nerve tissue activation) at the spinal cord, 50 times every second.
Algorithms process sensed signals in real time and adjust stimulation 50 times per second to maintain therapeutic settings as the patient moves.
Closed-loop keeps stimulation harmonized with body movement, preventing discomfort from bending, laughing, sneezing or other daily activities.
| Spec | Inceptiv closed-loop SCS |
|---|---|
| Sensing frequency | 50 times per secondR (reported) |
| MRI access | Full-body 3T MRI unrestrictedR (reported) |
| Form factor | Smallest and thinnest fully implantable SCSR (reported) |
R reported by the company
Medtronic
Medical devices, DBS, neuromodulation, surgery robots
Global medical technology company developing deep brain stimulation, neuromodulation, and surgical robots. Medtronic leads in adaptive DBS with Percept RC and in surgical robotics with Hugo RAS.